The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Open accessAbstract
Background: Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective: To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods: A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results: There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16 , BRCA 2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions: Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreas surveillance has been recommended for individuals estimated to be at high risk of developing PDAC (5% or higher estimated lifetime risk).5-8”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [5]
In the citing paper
“The US Preventive Services Task Force and other guidelines recommend against screening for pancreatic ductal adenocarcinoma in asymptomatic adults at average risk.6,53,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“All screening programmes for pancreatic ductal adenocarcinoma aim to detect and treat T1N0M0 cancers or high-grade dysplastic premalignant lesions (ie, pancreatic intraepithelial neoplasia 3 or mucinous cystic tumours with high-grade dysplasia).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“However, international guidelines and a white paper on the early detection of pancreatic ductal adenocarcinoma recommend targeted screening of individuals whose lifetime risk of developing pancreatic ductal adenocarcinoma is higher than 5% (figure 1).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp‐Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Tanaka, M., Chari, S. T., Adsay, V. N., Carlos, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2005) · Pancreatology · doi:10.1159/000090023 · Cited by 2,042
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
Self-citation
Cited by
Sorted by citations
Items 401–500 of 785
Park, H. J., Jang, K. M., Song, K. D., Kim, S. H., Kim, Y. K., Cha, M. J., Choi, S., & Min, K. (2017) · Clinical Radiology · doi:10.1016/j.crad.2017.07.009 · Cited by 11
Greco, L., Rubbino, F., & Laghi, L. (2022) · Cancers · doi:10.3390/cancers14235797 · Cited by 13
Pancreatic cancer.Evidence based management guidelines of the Hungarian Pancreatic Study Group
Szmola, R., Farkas, G., Hegyi, P. J., Czakó, L., Dubravcsik, Z., Hritz, I., Kelemen, D., Lásztity, N., Morvay, Z., Oláh, A., et al. (2015) · Orvosi Hetilap · doi:10.1556/oh.2015.30063 · Cited by 11
Screening for Pancreatic Cancer in High-risk Populations
Grover, S., & Jajoo, K. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.10.001 · Cited by 11
Chahla, E. J., Cheesman, A. R., Mahon, S. M., Garrett, R. W., Bradenham, B. P., Schwartz, T. L., Omran, L., Taylor, J. R., & Alkaade, S. (2016) · Scientifica · doi:10.1155/2016/5619358 · Cited by 11
Use of Precision Imaging in the Evaluation of Pancreas Cancer
Korn, R. L., Rahmanuddin, S., & Borazanci, E. H. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-16391-4_8 · Cited by 11
Risk Assessment and Genetic Testing for Inherited Gastrointestinal Syndromes.
Stoll, J., & Kupfer, S. S. (2019) · PubMed Central · Cited by 11
The association of Helicobacter pylori with pancreatic cancer
Kumar, S., Metz, D. C., Kaplan, D. E., & Goldberg, D. S. (2020) · GastroHep · doi:10.1002/ygh2.398 · Cited by 11
SOLDAN, M. (2017) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-69912017002015 · Cited by 11
Klein, A. P. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch124 · Cited by 11
Molecular imaging of pancreatic ductal adenocarcinoma
Huang, W., Huang, G., An, S., & Liu, J. (2023) · Open Research (University of Surrey) · doi:10.1002/viw.20230029 · Cited by 10
Maurer, E., Lehman, B., Matthäi, E., Denzer, U. W., Figiel, J. H., Jesinghaus, M., Slater, E. P., Stefenelli, U., Gress, T. M., & Bartsch, D. K. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12631 · Cited by 9
Cruz, L., Kwon, J. Y., Oman, S. P., Zaver, H. B., Bolaños, G. A., Kröner, P. T., Raimondo, M., Bi, Y., Lukens, F., & Corral, J. E. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.04.013 · Cited by 10
Pancreatic Cancer Surveillance: Who, When, and How
Dudley, B., & Brand, R. E. (2019) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-019-00247-0 · Cited by 12
Potjer, T. P. (2021) · Gut · doi:10.1136/gutjnl-2021-324739 · Cited by 10
Endoscopy to Diagnose and Prevent Digestive Cancers in Lynch Syndrome
Olivier, R., Randrian, V., Tougeron, D., & Saurin, J. (2021) · Cancers · doi:10.3390/cancers13143505 · Cited by 10
Eskander, M. F., Bliss, L. A., & Tseng, J. F. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.01.001 · Cited by 10
Potjer, T. P., Mertens, B. J. A., Nicolardi, S., van der Burgt, Y. E. M., Bonsing, B. A., Mesker, W. E., Tollenaar, R. A. �. �., & Vasen, H. F. A. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.03.003 · Cited by 10
Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis
Castro, M. P., Vierkoetter, K. R., Prager, D., Montgomery, S., & Sedgwick, K. (2016) · Case Reports in Oncology · doi:10.1159/000447348 · Cited by 10
Konings, I., Cahen, D., Harinck, F., Fockens, P., van Hooft, J. V., Poley, J., & Bruno, M. (2018) · Endoscopy International Open · doi:10.1055/a-0574-2396 · Cited by 8
Self-citationHaeri, H. H., Tomaszewski, J., Phytides, B., Schimm, H., Möslein, G., Niedergethmann, M., Hinderberger, D., & Gelos, M. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00116 · Cited by 10
Vasen, H. F. A. (2017) · Familial Cancer · doi:10.1007/s10689-017-0066-y · Cited by 10
Germline Genetic Testing for Pancreatic Ductal Adenocarcinoma at Time of Diagnosis
Syngal, S., & Furniss, C. S. (2018) · JAMA · doi:10.1001/jama.2018.6227 · Cited by 10
Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance
Grobbelaar, C. J., Kgomo, M. K., & Mabeta, P. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096284588240105051402 · Cited by 9
Silva-Santisteban, A., Woodbine, M. J. H., Noriega, M. A., Rabinowitz, L. G., Grimshaw, A. A., Farrell, J. J., Chhoda, A., & Sawhney, M. (2024) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.02.014 · Cited by 9
Ren, H., Mori, N., Hirasawa, M., Hamada, S., Mugikura, S., Masamune, A., & Takase, K. (2021) · Journal of Clinical Imaging Science · doi:10.25259/jcis_158_2021 · Cited by 9
Zannini, G., Facchini, G., SIO, M. D., Vita, F. D., Ronchi, A., Orditura, M., Vietri, M. T., Ciardiello, F., Franco, R., Accardo, M., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154336 · Cited by 9
Abboud, Y., Kim, K. J., Samaan, J. S., Chen, C. C., Lew, D., Ghaith, J., Caldera, W., Helou, M. O. E., Park, K. H., Liu, Q. Y., et al. (2023) · Pancreas · doi:10.1097/mpa.0000000000002213 · Cited by 9
Surveillance of patients with hereditary gastrointestinal cancer syndromes
Moreira, L., & Castells, A. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.10.004 · Cited by 9
Mizuno, S., Isayama, H., Nakai, Y., Ishigaki, K., Saito, K., Sato, T., Takeda, T., Hakuta, R., Saito, T., Takahara, N., et al. (2019) · Pancreatology · doi:10.1016/j.pan.2019.07.002 · Cited by 9
Quality of life impact of EUS in patients at risk for developing pancreatic cancer
Bhutani, M., Cazacu, I. M., Chavez, A. L., Mendoza, T. R., Qiao, W., Singh, B. S., Bokhari, R. H., Săftoiu, A., Lee, J., Weston, B. R., et al. (2019) · Endoscopic Ultrasound · doi:10.4103/eus.eus_56_19 · Cited by 8
Abe, K., Kitago, M., Kosaki, K., Yamada, M., Iwasaki, E., Kawasaki, S., Mizukami, K., Momozawa, Y., Terao, C. C., Yagi, H., et al. (2022) · Cancer Science · doi:10.1111/cas.15316 · Cited by 9
Wang, Y., Cuggia, A., Chen, Y., Parent, J., Stanek, A., Denroche, R. E., Zhang, A. X. W., Grant, R. C., Domecq, C., Golesworthy, B., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.7107 · Cited by 9
Adenosquamous carcinoma of the pancreas: two case reports and review of the literature
Paramythiotis, D., Kyriakidis, F., Karlafti, E., Didangelos, T., Oikonomou, I. M., Karakatsanis, A., Poulios, C., Chamalidou, E., Vagionas, A., & Michalopoulos, A. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03610-5 · Cited by 9
Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
Llach, J., Aguilera, P., Sánchez, A., Ginés, À., Fernández‐Esparrach, G., Soy, G., Sendino, O., Vaquero, E. C., Carballal, S., Ausania, F., et al. (2023) · Cancers · doi:10.3390/cancers15061690 · Cited by 9
Familial Pancreatic Cancer: Challenging Diagnostic Approach and Therapeutic Management
Mastoraki, A. T., Chatzimavridou-Grigoriadou, V., Chatzipetrou, V., Mastoraki, S., Papanikolaou, I. S., Danias, N., Smyrniotis, V. E., & Arkadopoulos, N. F. (2014) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-014-9609-8 · Cited by 9
Familial pancreatic cancer risk: a population-based study in Utah
Kohli, D. R., Smith, K. R., Wong, J., Yu, Z., Boucher, K. M., Faigel, D. O., Pannala, R., Burt, R. W., Curtin, K. P., & Samadder, N. J. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01597-3 · Cited by 9
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice
Ascrizzi, S., Arillotta, G. M., Grillone, K., Caridà, G., Signorelli, S., Ali, A., Romeo, C., Tassone, P., & Tagliaferri, P. (2023) · Cancers · doi:10.3390/cancers15153930 · Cited by 8
Archibugi, L., Casciani, F., Carrara, S., Secchettin, E., Falconi, M., Capurso, G., & Paiella, S. (2024) · Familial Cancer · doi:10.1007/s10689-024-00366-3 · Cited by 8
Siegel, A., Friedman, M., Feldman, D., Krishnan, K., Casey, B. W., Pisuchpen, N., Kambadakone, A. R., & Chung, D. C. (2022) · Pancreatology · doi:10.1016/j.pan.2022.07.015 · Cited by 8
Bernstein‐Molho, R., Friedman, E., & Evron, E. (2022) · Cancers · doi:10.3390/cancers14194592 · Cited by 8
Cao, C., Sharib, J. M., Blanco, A. M., Goldberg, D., Bracci, P. M., Mukhtar, R. A., Esserman, L. J., & Kirkwood, K. S. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.09.019 · Cited by 8
Wang, C., Tseng, M., Wu, S., Yang, T., Chen, H., Sung, W., Su, C., Wang, Y., Chen, W., Lai, H., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15234 · Cited by 8
Murali, K., Dwarte, T. M., Nikfarjam, M., Tucker, K., Vaughan, R., Efthymiou, M., Collins, A., Spigelman, A. D., Salmon, L., Johns, A. L., et al. (2021) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-021-00190-1 · Cited by 8
Impact of COVID-19 on pancreatic cancer surgery: A high-volume Polish center experience
Kędzierska-Kapuza, K., Witkowski, G., Baumgart, K., Szylińska, A., & Durlik, M. (2022) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/144134 · Cited by 9
Fukushima, G., Abe, K., Kitago, M., Iwasaki, E., Hirata, A., Takemura, R., Ishii, R., Yagi, H., Abe, Y., Hasegawa, Y., et al. (2022) · Pancreas · doi:10.1097/mpa.0000000000002064 · Cited by 8
The Utility of Artificial Intelligence in the Diagnosis and Management of Pancreatic Cancer
Kumar, V., Gaddam, M., Moustafa, A., Iqbal, R., Gala, D., Shah, M., Gayam, V. B. R., Bandaru, P., Reddy, M., & Gadaputi, V. (2023) · Cureus · doi:10.7759/cureus.49560 · Cited by 9
New strategies for the early detection of pancreatic cancer
Petrone, M., & Arcidiacono, P. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1122521 · Cited by 8
Dynamic nuclear polarisation: The future of imaging in oncology?
Serrão, E. M., & Brindle, K. M. (2017) · Porto Biomedical Journal · doi:10.1016/j.pbj.2017.01.002 · Cited by 8
DPSCREEN: Dynamic Personalized Screening
Ahuja, K., Zame, W. R., & van der Schaar, M. (2017) · neural information processing systems · Cited by 8
High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers
Ibrahim, I. S., Wasser, M. N. J. M., Wu, Y., Inderson, A., Cappel, W. H. D. V. T. N., Morreau, H., Hes, F. J., Veenendaal, R. A., Putter, H., Feshtali, S., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0035 · Cited by 8
Talking Genes in Breast and Pancreatic Malignancies
Barbara, M., Tsen, A., Tenner, L. L., & Rosenkranz, L. A. (2019) · Materia Socio Medica · doi:10.5455/msm.2019.31.146-149 · Cited by 8
Dwarte, T. M., McKay, S., Johns, A. L., Tucker, K., Spigelman, A. D., Williams, D. B., & Stoita, A. (2019) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-019-0129-1 · Cited by 8
S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1
Seufferlein, T. T. W., Mayerle, J. V., Boeck, S. H., Brunner, T. B., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A. M. R., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2338-3533 · Cited by 7
Stefàno, E., Cossa, L. G., Castro, F. D., Luca, E. D., Vergaro, V., My, G., Rovito, G., Migoni, D., Muscella, A., Marsigliante, S., et al. (2023) · Bioinorganic Chemistry and Applications · doi:10.1155/2023/5564624 · Cited by 7
McNamara, G. P. J., Ali, K. N., Vyas, S., Huynh, T., Nyland, M., Almanza, D., Laronga, C., Klapman, J. B., & Permuth, J. B. (2018) · Gastrointestinal Disorders · doi:10.3390/gidisord1010008 · Cited by 7
Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result
Zhu, X., Leof, E. R., Rabe, K. G., McCormick, J. B., Petersen, G. M., & Breitkopf, C. R. (2018) · Public Health Genomics · doi:10.1159/000496556 · Cited by 7
Leof, E. R., Zhu, X., Rabe, K. G., McCormick, J. B., Petersen, G. M., & Breitkopf, C. R. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0517-y · Cited by 7
Surveillance for the early diagnosis of familial pancreatic cancer (Expert consensus)
Kitano, M., Morizane, C., Hijioka, S., Matsubayashi, H., Ashida, R., Ikeura, T., Ito, T., Kamisawa, T., Kawaguchi, T., Kawabe, K., et al. (2020) · Suizo · doi:10.2958/suizo.35.322 · Cited by 7
Kim, S. H., Hwang, H. K., Lee, W. J., & Kang, C. M. (2021) · Pancreatology · doi:10.1016/j.pan.2021.02.007 · Cited by 7
Molero, X., Ayuso, J. R., Balsells, J., Boadas, J., Busquets, J., Casteràs, A., Concepción, M., Cuatrecasas, M., Fernández‐Esparrach, G., Fort, E., et al. (2021) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2021.05.016 · Cited by 7
Prävention gastrointestinaler Tumore
Teufel, A., Quante, M., Kandulski, A., Hirth, M., Zhan, T., Eckardt, M., Thieme, R., Kusnik, A. T., Yesmembetov, K., Wiest, I., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1540-7539 · Cited by 7
Early Detection of Pancreatic Cancer: Risk Factors and the Current State of Screening Modalities.
Keihanian, T., Barkin, J. A., & Souto, E. O. (2021) · PubMed Central · Cited by 7
Nero, L. D., Dabizzi, E., Ceglie, A. D., Ziola, S., Zerbi, A., Baron, T. H., & Conio, M. (2023) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2023.102079 · Cited by 7
Raff, J. P., Cook, B., Jafri, F. N., Boxer, N., Maldonado, J., Hopkins, U. T., Roayaie, S., & Noyer, C. M. (2022) · Pancreas · doi:10.1097/mpa.0000000000002182 · Cited by 7
Nicholson, J., Greenhalf, W., Jackson, R., Cox, T. F., Butler, J. V., Hanna, T., Harrison, S., Grocock, C., Halloran, C. M., Howes, N., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000246 · Cited by 7
Hereditary colorectal cancer syndromes
Carballal, S., Leoz, M. L., Moreira, L., Ocaña, T., & Balaguer, F. (2014) · Colorectal Cancer · doi:10.2217/crc.13.80 · Cited by 7
Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis
Fujita, Y., Kitago, M., Masugi, Y., Itano, O., Shinoda, M., Abe, Y., Hibi, T., Yagi, H., Fujii‐Nishimura, Y., Sakamoto, M., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9222 · Cited by 7
Japanese Familial Pancreatic Cancer Registry with the aim to early detection of pancreatic cancer
Morizane, C., Kitano, M., Hijioka, S., Ito, T., Kamisawa, T., Kosugi, S., Furukawa, T., Furuse, J., Majima, Y., Matsubayashi, H., et al. (2017) · Suizo · doi:10.2958/suizo.32.23 · Cited by 7
Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News
Hruban, R. H. (2019) · Pancreas · doi:10.1097/mpa.0000000000001299 · Cited by 7
Self-citationSchwartz, M., Korenbaum, C., Meriem, B., Mary, M., Colas, C., Coulet, F., Mélissa, P., Jonveaux, P., Ingster, O., Granier, S., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13629 · Cited by 7
Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy
Grapa, C. M., MOCAN, L. C., Crișan, D., Florea, M., & Mocan, T. (2021) · Materials · doi:10.3390/ma14113083 · Cited by 7
Saldia, A., Olson, S. H., Nunes, P., Liang, X., Samson, M. L., Salo‐Mullen, E. E., Marcell, V. J., Stadler, Z. K., Allen, P. J., Offit, K., et al. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0272 · Cited by 7
Kobayashi, T., & Honda, K. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1643718 · Cited by 7
Lu, Y., Wang, P., Liu, H., Li, T., Wang, H., Jiang, D., Liu, L., & Ye, H. (2024) · Nutrients · doi:10.3390/nu16213723 · Cited by 6
Mansfield, S. A., Pilarski, R., & Agnese, D. M. (2016) · Familial Cancer · doi:10.1007/s10689-016-9959-4 · Cited by 6
Screening for Pancreatic Cancer—Is There Hope?
Lennon, A. M., Hruban, R. H., & Klein, A. P. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.3323 · Cited by 7
Self-citationA case of sporadic Peutz-Jeghers syndrome presenting as multiple intussusceptions
Gorji, L., Huish, G., Morgan, J., & Levy, P. (2022) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjac070 · Cited by 6
Hunt, K. S., Ray, J. A., & Jeter, J. (2013) · Springer eBooks · doi:10.1007/978-3-642-38983-2_5 · Cited by 6
Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging?
Vullierme, M., & Lagadec, M. (2016) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2016.08.018 · Cited by 8
Screening for pancreatic cancer: a review for general clinicians
Wiest, N. E., Moktan, V. P., Oman, S. P., & Chirilă, R. M. (2020) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2020-0009 · Cited by 6
Roberts, N. J., & Klein, A. P. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_78 · Cited by 6
Whipple procedure: patient selection and special considerations
Tan-Tam, C., Segedi, M., & Chung, S. (2016) · Open Access Surgery · doi:10.2147/oas.s99636 · Cited by 6
Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
Abe, K., Ueki, A., Urakawa, Y., Kitago, M., Yoshihama, T., Nanki, Y., Kitagawa, Y., Aoki, D., Kosaki, K., & Hirasawa, A. (2021) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-020-00160-z · Cited by 6
Limited resection of pancreatic cancer in high-risk patients can result in a second primary: Table 1
Potjer, T. P., Bartsch, D. K., Slater, E. P., Matthäi, E., Bonsing, B. A., & Vasen, H. F. A. (2015) · Gut · doi:10.1136/gutjnl-2015-309568 · Cited by 6
Pancreatic cancer screening in high-risk individuals: Ready for prime time?
Bruno, M. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.02.011 · Cited by 6
Self-citationEarly Detection of Pancreatic Cancer in High-Risk Individuals: Where Do We Go From Here?
Hart, P. A. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000192 · Cited by 6
Aijazi, M., Fasanella, K. E., McGrath, K., Smith, L. M., Singhi, A. D., & Brand, R. E. (2024) · Pancreas · doi:10.1097/mpa.0000000000002312 · Cited by 5
A Systematic Review of Cost-Effectiveness Studies on Pancreatic Cancer Screening
Lewis, D., Jiménez, L., Chan, K., Horton, S., & Wong, W. W. L. (2025) · Current Oncology · doi:10.3390/curroncol32040225 · Cited by 5
Epidemiology Of Hospitalizations For Malignant Pancreatic Neoplasm In Brazil
Santos, J. V. F., & de Prince, K. A. (2023) · Seven Editora eBooks · doi:10.56238/colleinternhealthscienv1-103 · Cited by 5
Prediction of Pancreatic Cancer Risk in Patients with New-Onset Diabetes
Khan, S. (2025) · Visceral Medicine · doi:10.1159/000543479 · Cited by 5
Kim, Y.-E., Yu, M. H., Nam, C. M., & Kang, E. S. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0277 · Cited by 7
Sherchan, A., Jin, F., Sherchan, B., Mandal, S. K., Regmi, B. U., Ghising, R., Upadhaya, S. R., Gautam, B., Pathak, D., & Li, M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1551926 · Cited by 5
Vukobrat-Bijedić, Z., Husić-Selimović, A., Bijedić, N., Gornjakovic, S., Sofić, A., Gogov, B., Bjelogrlic, I., Mehmedović, A., & Glavaš, S. (2014) · Acta Informatica Medica · doi:10.5455/aim.2014.22.160-163 · Cited by 5
Tavano, F., Gioffreda, D., Fontana, A., Palmieri, O., Gentile, A., Latiano, T. P., Latiano, A., Latiano, T. P., Scaramuzzi, M., Maiello, E., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00600-1 · Cited by 5
Hasoğlu, İ., & Kaçar, A. K. (2023) · PROTOPLASMA · doi:10.1007/s00709-023-01896-w · Cited by 5
Grigorie, R. T., Potlog, G., & Alexandrescu, S. T. (2025) · Medicina · doi:10.3390/medicina61010120 · Cited by 5
Uchida, D., Kato, H., Matsumoto, K., Ishihara, Y., Matsumi, A., Saragai, Y., Takada, S., Yabe, S., Muro, S., Tomoda, T., et al. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1141-7 · Cited by 5
Ha, C. S. R., Müller‐Nurasyid, M., Petrera, A., Hauck, S. M., Marini, F., Bartsch, D. K., Slater, E. P., & Strauch, K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280399 · Cited by 5
Metadata
- Authors
- Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., Levy, M. J., Chak, A., Fockens, P., Goggins, M., & Bruno, M.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Utrecht University (NL)
- Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
- Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
- University of Verona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mayo Clinic (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Canto, Marcia Irene
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-11-07
- Volume
- 62
- Issue
- 3
- Pages
- 339-347
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC3585492
- OpenAlex
- W2111705409
- Cited by
- 784
- References
- 88
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 40 · 2023: 53 · 2022: 66 · 2021: 73 · 2020: 61 · 2019: 82 · 2018: 82 · 2017: 67 · 2016: 71 · 2015: 69 · 2014: 45 · 2013: 23 · 2012: 6
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (K24CA113433, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer screening, familial pancreatic cancer, genetic susceptibility, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, Peutz-Jeghers syndrome, BRCA2 mutation carriers, Lynch syndrome, endoscopic ultrasound, surveillance interval, surgical management, high-volume centers, multidisciplinary team, consensus recommendations
- MeSH terms
- Age Factors, Carcinoma, Follow-Up Studies, Humans, Mutation, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Risk Factors, Treatment Outcome, Endosonography, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
